AC Immune (ACIU) Competitors $2.06 +0.04 (+1.98%) Closing price 07/3/2025 02:31 PM EasternExtended Trading$2.06 0.00 (0.00%) As of 07/3/2025 04:51 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Competitors Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsHeadlinesOptions ChainOwnershipSEC FilingsShort InterestTrendsBuy This Stock ACIU vs. CMRX, CDMO, AVBP, SNDX, IMNM, QURE, PHAR, XERS, CRON, and MENSShould you be buying AC Immune stock or one of its competitors? The main competitors of AC Immune include Chimerix (CMRX), Avid Bioservices (CDMO), ArriVent BioPharma (AVBP), Syndax Pharmaceuticals (SNDX), Immunome (IMNM), uniQure (QURE), Pharming Group (PHAR), Xeris Biopharma (XERS), Cronos Group (CRON), and Jyong Biotech (MENS). These companies are all part of the "pharmaceutical products" industry. AC Immune vs. Its Competitors Chimerix Avid Bioservices ArriVent BioPharma Syndax Pharmaceuticals Immunome uniQure Pharming Group Xeris Biopharma Cronos Group Jyong Biotech AC Immune (NASDAQ:ACIU) and Chimerix (NASDAQ:CMRX) are both small-cap medical companies, but which is the better stock? We will contrast the two businesses based on the strength of their valuation, dividends, earnings, risk, profitability, analyst recommendations, institutional ownership and media sentiment. Which has preferable earnings and valuation, ACIU or CMRX? AC Immune has higher revenue and earnings than Chimerix. Chimerix is trading at a lower price-to-earnings ratio than AC Immune, indicating that it is currently the more affordable of the two stocks. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioAC Immune$28.30M7.31-$57.83M-$0.58-3.55Chimerix$212K3,778.71-$82.10M-$0.99-8.63 Does the media refer more to ACIU or CMRX? In the previous week, AC Immune had 1 more articles in the media than Chimerix. MarketBeat recorded 1 mentions for AC Immune and 0 mentions for Chimerix. AC Immune's average media sentiment score of 0.59 beat Chimerix's score of 0.00 indicating that AC Immune is being referred to more favorably in the media. Company Overall Sentiment AC Immune Positive Chimerix Neutral Is ACIU or CMRX more profitable? Chimerix has a net margin of 0.00% compared to AC Immune's net margin of -177.79%. AC Immune's return on equity of -44.60% beat Chimerix's return on equity.Company Net Margins Return on Equity Return on Assets AC Immune-177.79% -44.60% -22.25% Chimerix N/A -50.78%-44.94% Which has more risk and volatility, ACIU or CMRX? AC Immune has a beta of 1.62, indicating that its share price is 62% more volatile than the S&P 500. Comparatively, Chimerix has a beta of -0.17, indicating that its share price is 117% less volatile than the S&P 500. Do analysts rate ACIU or CMRX? AC Immune currently has a consensus price target of $12.00, indicating a potential upside of 482.52%. Chimerix has a consensus price target of $8.53, indicating a potential downside of 0.08%. Given AC Immune's stronger consensus rating and higher possible upside, analysts plainly believe AC Immune is more favorable than Chimerix.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score AC Immune 0 Sell rating(s) 0 Hold rating(s) 1 Buy rating(s) 0 Strong Buy rating(s) 3.00Chimerix 0 Sell rating(s) 3 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 2.00 Do institutionals and insiders believe in ACIU or CMRX? 51.4% of AC Immune shares are owned by institutional investors. Comparatively, 45.4% of Chimerix shares are owned by institutional investors. 4.6% of AC Immune shares are owned by company insiders. Comparatively, 13.1% of Chimerix shares are owned by company insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a stock will outperform the market over the long term. SummaryAC Immune beats Chimerix on 13 of the 16 factors compared between the two stocks. Get AC Immune News Delivered to You Automatically Sign up to receive the latest news and ratings for ACIU and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding ACIU and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart ACIU vs. The Competition Export to ExcelMetricAC ImmuneMED IndustryMedical SectorNASDAQ ExchangeMarket Cap$207.85M$2.92B$5.56B$9.05BDividend YieldN/A2.44%5.24%4.01%P/E Ratio-3.5521.5627.6120.24Price / Sales7.31278.20416.87118.48Price / CashN/A42.7336.8958.10Price / Book1.607.518.035.67Net Income-$57.83M-$55.14M$3.18B$249.21M7 Day Performance2.49%4.61%2.93%3.28%1 Month Performance19.08%4.72%3.75%5.55%1 Year Performance-42.62%5.92%35.20%21.09% AC Immune Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)ACIUAC Immune2.4516 of 5 stars$2.06+2.0%$12.00+482.5%-45.9%$207.85M$28.30M-3.55140CMRXChimerix0.6314 of 5 stars$8.54flat$8.53-0.1%N/A$801.09M$212K-9.0990CDMOAvid Bioservices0.6956 of 5 stars$12.50+0.1%$12.25-2.0%+62.3%$799.18M$139.91M-5.23320High Trading VolumeAVBPArriVent BioPharma1.7479 of 5 stars$21.77-5.0%$40.00+83.7%+13.6%$783.81MN/A-5.7740SNDXSyndax Pharmaceuticals3.1359 of 5 stars$9.36+3.5%$35.80+282.5%-53.8%$777.87M$23.68M-2.42110IMNMImmunome2.4641 of 5 stars$9.30+6.0%$23.33+150.9%-28.1%$763.10M$9.04M-2.9240High Trading VolumeQUREuniQure1.9708 of 5 stars$13.94+0.6%$37.82+171.3%+270.5%$759.19M$27.12M-3.18500News CoveragePHARPharming Group2.9011 of 5 stars$10.68-2.9%$30.00+181.0%+23.1%$748.58M$297.20M-53.38280Positive NewsGap DownHigh Trading VolumeXERSXeris Biopharma3.9135 of 5 stars$4.67-0.6%$6.25+33.8%+128.6%$735.01M$203.07M-15.57290Positive NewsCRONCronos Group2.2709 of 5 stars$1.91+0.5%N/A-12.1%$732.80M$117.61M14.69450News CoverageMENSJyong BiotechN/A$8.50-10.5%N/AN/A$722.26MN/A0.0031 Related Companies and Tools Related Companies Chimerix Competitors Avid Bioservices Competitors ArriVent BioPharma Competitors Syndax Pharmaceuticals Competitors Immunome Competitors uniQure Competitors Pharming Group Competitors Xeris Biopharma Competitors Cronos Group Competitors Jyong Biotech Competitors Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (NASDAQ:ACIU) was last updated on 7/5/2025 by MarketBeat.com Staff From Our PartnersA new rule goes live in July — and the banks are quietly cashing inA little-known regulation quietly goes into effect this July. And it's already being exploited by Wall Stre...American Alternative | SponsoredIs Elon's empire crumbling?The Tesla Shock Nobody Sees Coming While headlines scream "Tesla is doomed"... Jeff Brown has uncovered ...Brownstone Research | SponsoredPresidential Bombshell: $150T Resource to Be Released as soon as this Summer?Something extraordinary is happening in Washington. For the first time in over a century, a sitting Preside...Paradigm Press | SponsoredPost-Halving = Profit Season (Here’s How to Win It)It happens like clockwork. Every four years, the crypto market enters a new phase — and for those who know how...Crypto Swap Profits | SponsoredTrump’s New Order Could Boost Social Security Benefits by 400%If you collect—or plan to collect—Social Security, you need to see this. A new initiative tied to President...InvestorPlace | SponsoredThe #1 AI Energy StockNearly $600 billion is projected to be spent on AI data centers this year. That's because the ones being bu...Weiss Ratings | SponsoredINVESTOR ALERT: Tiny “$3 AI Wonder Stock” on the Verge of Blasting OffRight now, we’re witnessing a monumental shift in the world.Traders Agency | SponsoredWhite House to reset Social Security?Elon Musk's parting DOGE gift looks set to shock America... A single announcement by July 22nd could soon b...Altimetry | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding AC Immune Please log in to your account or sign up in order to add this asset to your watchlist. Share AC Immune With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Free ACIU Stock Alerts